Such as, SLC16A12 is a creatine transporter for creatine and guanidinoacetate in the kidney [48], and its expression level predicates a favorable prognosis for ccRCC patients [49]. This evidence concerns the gene SLC16A12 and nonpapillary renal cell carcinoma.